• Stable Isotope UHPLC–MS/MS for Methylated Purines

  2026-09-05

  The 2024 Analytical Chemistry study developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow for accurate measurement of 12 purine ribonucleosides, including 10 methylated species. Enhanced ionization, chromatographic resolution of methylated isomers, and matrix-reduction steps enabled sensitive intracellular quantification relevant to RNA modification research, cancer metabolism studies, and biomarker discovery.

• (±)-Blebbistatin for Spatial Cell Mechanics

  2026-09-04

  Use (±)-Blebbistatin to reversibly reduce non-muscle myosin II activity while measuring migration, adhesion, and morphology with spatially resolved imaging. Inspired by panoramic cardiac mapping, this workflow links a mechanical perturbation to local cell behavior instead of treating an image as a purely descriptive endpoint.

• YTHDF1–THBS1 Control of Osteogenesis under Hypoxia

  2026-09-04

  The reference study identifies YTHDF1 as a hypoxia-responsive m6A reader that counteracts impaired osteogenic differentiation in MC3T3-E1 cells through post-transcriptional regulation of THBS1. Its combination of gene perturbation, osteogenic phenotyping, and RNA-level analyses provides a mechanistic framework for studying hypoxia-related bone loss in peri-implantitis.

• TEAC: From K+ Pores to Translational Strategy

  2026-09-03

  Tetraethylammonium chloride (TEAC) is more than a broad potassium-channel blocker: it is a mechanistic perturbation tool for connecting pore conduction with cellular, vascular, and translational phenotypes. This article integrates ion-channel biology, evidence from pancreatic beta-cell research, experimental design, product considerations, and strategic guidance for interpreting TEAC-driven results.

• AR Heterogeneity Shapes Castration and Enzalutamide Response

  2026-09-03

  Li and colleagues show that androgen receptor heterogeneity is not merely a descriptive feature of advanced prostate cancer: nuclear, mixed nuclear/cytoplasmic, and AR-low or negative states display different tumor behavior and responses to castration or enzalutamide. By combining patient samples, xenografts, isogenic genome-edited models, RNA sequencing, and combination treatment experiments, the study identifies BCL-2 as a potential vulnerability for AR-low or negative disease.

• HotStart Universal 2X Green qPCR Master Mix

  2026-09-02

  Build reproducible real-time PCR gene expression analysis around a hot-start enzyme, Green I fluorescence, and a universal ROX reference system. This workflow translates a finishing-pig Eucommia ulmoides leaf extract study into practical assay design, from tissue cDNA and dose-response panels to melt-curve verification and troubleshooting.

• Protein A/G Magnetic Beads: Practical IP Guide

  2026-09-02

  Protein A/G Magnetic Beads provide Fc-directed capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin workflows from complex samples. This guide explains setup, controls, and troubleshooting while defining limits for Fc-lacking antibody fragments, unvalidated assay conditions, and diagnostic or medical use.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-09-01

  The reference study combines genetic models, inducible postnatal deletion, chondrocyte assays, and pharmacological inhibition to show that excessive FGFR3 signaling contributes to SLC26A2-related skeletal dysplasia in mice. Its findings support FGFR3 pathway inhibition as a research direction for improving chondrocyte differentiation, survival, and bone microarchitecture, while leaving human efficacy and dosing questions unresolved.

• Rotenone and Mitochondria-to-Peroxisome Stress

  2026-09-01

  Rotenone is best known as a mitochondrial Complex I inhibitor, but its value extends to studying how mitochondrial stress may intersect with organelle quality control. This article translates new findings on MARCH5-dependent pre-peroxisome formation into a practical framework for designing mechanistically separated rotenone assays.

• BODIPY 581/591 C11 for Lipid Peroxidation

  2026-08-31

  BODIPY 581/591 C11 converts membrane oxidation into a measurable red-to-green fluorescence ratio, supporting live-cell lipid peroxidation detection without relying on a single intensity value. This workflow guide shows how to apply the probe to antioxidant capacity evaluation, nanozyme studies, and cardiovascular oxidative stress experiments while avoiding common interpretation errors.

• HyperFusion high-fidelity DNA polymerase for C. elegans PCR

  2026-08-31

  HyperFusion™ high-fidelity DNA polymerase combines proofreading accuracy with robust amplification of GC-rich, long, or inhibitor-containing templates. This article shows how to apply it to C. elegans genotyping, cloning, targeted sequencing, and mechanistic studies inspired by pheromone-linked neurodegeneration research.

• Thioguanine: Reproducible Cell Assay Workflows

  2026-08-30

  This scenario-driven guide explains how Thioguanine, SKU A4176, can reduce common formulation, dosing, and interpretation problems in cell viability, proliferation, and antiviral assays. It connects product handling data with published EV71 results and practical controls for more defensible laboratory decisions.

• Tankyrase Inhibitors and Hippo Signaling in HCC

  2026-08-29

  Jia et al. showed that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth through a mechanism involving AMOTL1/2 stabilization, reduced YAP activity, and inhibition of the Hippo effector program. The study broadens interpretation of tankyrase inhibition beyond Wnt/β-catenin signaling and provides a rationale for testing combinations with MEK or AKT pathway inhibitors.

• FGFR3 Signaling in SLC26A2 Chondrodysplasia

  2026-08-28

  This study combines genetic models, inducible disease modeling, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. Its findings support NVP-BGJ398 as a mechanistic research tool and provide preclinical evidence for targeting FGFR3 to improve chondrocyte function and skeletal development.

• Rotenone Workflows for Mitochondrial Stress Research

  2026-08-28

  Rotenone provides a controlled way to connect mitochondrial Complex I inhibition with ROS, ATP loss, apoptosis, and stress signaling. This practical guide combines cell-based workflows, Parkinson’s disease model considerations, and a reference-informed strategy for testing how mitochondrial ROS may influence NEMO–RelA signaling.

7924 records 1/529 page Next 12345 下5页 Last page